Increase your knowledge on cancer immunotherapy
Cancer immunotherapeutic approaches are based on the generally-accepted hypothesis that the immune system is the best tool humans have to fight diseases. How that works? Read about cancer immunotherapy and get free downloads at our NEW knowledge center webpages!
In the western world, 1 out of 3 people develop cancer: most of us know someone in their social circle that suffers this disease. And although progress has been made the past years to treat cancer, the disease is very complicated, making it difficult to find the ever-wanting cure.
The complexity of cancer
Cancer is complicated: the disease consists of over 100 distinct cancer types that manifest in approximately 200 cell types. Cancers develop over time in 5-10% of the cases due to genetic inheritance. The majority of cancers however (70-90%) are the result of a wide range of environmental risk factors. So where do you begin when you want to treat cancer effectively?
Cancer Immunotherapy: the breakthrough
Immunotherapeutic approaches to treat cancer are rapidly making headway and it has been stated as the breakthrough of the year 2013 by Science magazine. 
Such approaches are based on the hypothesis that the immune system is the best tool humans have to fight diseases, including cancers. To this end, the patient's immune system can be actively stimulated so that the immune cells can recognize and effectively kill cancer cells.
Get more insights and free downloads on cancer immunotherapy
At Westburg, we care for good research. Therefore, we started developing a knowledge center within our website to help you get more insights into various research areas and their latest technologies. Lucky you: we kick off with cancer immunotherapy applications!
Feel free to nose about how to fight cancer with cancer immunotherapy and get yourself some valuable (and free!) downloads. You can also gain more insights by watching some interesting videos, see some of the latest protocols and many more.
1. Jennifer Couzin-Frankel. Cancer Immunotherapy. Science; 20 Dec 2013: Vol. 342, Issue 6165, pp. 1432-1433